FAP and neoplasm: Significant uptake and long tumor retention of 177Lu-FAP-2286 resulted in high absorbed tumor doses, such as 3.0 ± 2.7 Gy/GBq (range, 0.5–10.6 Gy/GBq) in bone metastases.